NEW YORK, Sept. 21, 2016 /PRNewswire/ -- Hynes Keller &
Hernandez, LLC is investigating potential claims against the Board
of Directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the
"Company")(NASDAQ: SPPI) arising from possible breaches of
fiduciary duty by certain of its officers and directors in
connection with the Company's pursuit of Food and Drug
Administration approval of its proposed bladder cancer drug
apaziquone.
Click here for more information about our investigation of
SPPI:
http://hkh-lawfirm.com/investigations-cases/spectrum-pharmaceuticals-inc-sppi/
Hynes Keller & Hernandez, LLC is a national law firm
that represents institutional and individual investors. The
firm is focused on providing exemplary legal services in the area
of shareholder litigation. The firm has an experienced litigation
team which has achieved significant victories on behalf of the
firm's clients. You can visit our website at
www.hkh-lawfirm.com for more information. Attorney
advertising. Prior results do not guarantee similar outcomes.
If you hold shares in SPPI and would like to obtain additional
information about your legal rights and protect your investment,
please visit our website or contact the attorneys below.
There is no cost or obligation to you.
|
Contact:
|
|
|
|
|
Hynes Keller &
Hernandez,
LLC
|
Hynes Keller
& Hernandez, LLC
|
|
Michael J. Hynes,
Esq.
|
Beth A. Keller,
Esq.
|
|
1150 First Avenue,
Suite
501
|
118 North
Bedford Road, Suite 100
|
|
King of Prussia, PA
19406
|
Mount Kisco, NY
10549
|
|
Telephone: (610)
994-0292
|
Telephone:
(914) 752-3040
|
|
Email:
mhynes@hkh-lawfirm.com
|
Email:
bkeller@hkh-lawfirm.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hynes-keller--hernandez-llc-announces-investigation-of-spectrum-pharmaceuticals-inc-sppi-300331550.html
SOURCE Hynes Keller & Hernandez, LLC